Irit Arbel, Director at Brainstorm Cell Therapeutics, holds 155.83K shares in Brainstorm Cell Therapeutics (Ticker: BCLI), holds 0.00 shares in Pluri (Ticker: PLUR). Most recently, Irit Arbel Sold ― shares of Brainstorm Cell Therapeutics on Aug 30, 2019 for an estimated value of 48.80K.
What is the percentage of profitable transactions made by Irit Arbel?
The percentage of profitable transactions made by Irit Arbel is 0%.
What is the average return per transaction made by Irit Arbel?
The average return per transaction made by Irit Arbel is -121.60%.
What stocks does Irit Arbel hold?
Irit Arbel holds: BCLI, PLUR stocks.
What was Irit Arbel’s latest transaction?
Irit Arbel latest transaction was an Informative Sell of $48.80K.
What was Irit Arbel's most profitable transaction?
Irit Arbel’s most profitable transaction was an Informative Buy of BCLI stock on August 31, 2017. The return on the trade was -7.00%.
What is Irit Arbel's role in Brainstorm Cell Therapeutics?
Irit Arbel's role in Brainstorm Cell Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.